EXHALATION MEDICAL TECHNOLOGY LTD, Cambridge, 英国

股东名单

名称	持股	表决权	自

最终实益拥有人

名称	权益	国家/地区	自

财务

主要数据来自年度账目申报。

转换为

2012

利润/（亏损）: £-29.6K

主要数据

利润/（亏损）

2012£-29,584

2013£-107,864

2014£-111,186

2015£-111,875

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

总资产

2012£10,630

2013£-65,753

2014£-62,550

2015£-62,904

2016£-51,588

2017£51,806

2018£52,227

2019£52,227

2020£52,279

2021£23,853

2022£108

2023£199

Net Assets Liabilities

2012—

2013—

2014—

2015—

2016—

2017£51,806

2018£52,227

2019£52,227

2020£52,279

2021—

2022—

2023—

Equity

2012—

2013—

2014—

2015—

2016—

2017£51,806

2018£52,227

2019£52,227

2020£52,279

2021£23,853

2022£108

2023—

Current Assets

2012£12,104

2013£164

2014£661

2015£721

2016£5,180

2017£4,829

2018£4,771

2019£4,771

2020£4,719

2021£39,104

2022£20,709

2023£199

Net Current Assets Liabilities

2012£10,630

2013£-65,753

2014£661

2015£721

2016£5,180

2017£51,806

2018£52,227

2019£4,771

2020£4,719

2021—

2022—

2023—

Total Assets Less Current Liabilities

2012£10,630

2013£-65,753

2014£661

2015£721

2016£5,180

2017£51,806

2018£52,227

2019£4,771

2020£4,719

2021—

2022—

2023—

Debtors

2012£2,581

2013£164

2014£257

2015£252

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Creditors

2012—

2013—

2014—

2015—

2016—

2017£56,635

2018£56,998

2019£56,998

2020£56,998

2021£15,250

2022£20,601

2023£199

Number Shares Allotted

2012226,300

2013247,064

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Par Value Share

2012—

2013£0

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Average Number Employees During Period

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019—

20201

20210

20220

20230

Accrued Liabilities Not Expressed Within Creditors Subtotal

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021£1

2022—

2023—

Called Up Share Capital

2012£11,315

2013£12,353

2014£18,878

2015£22,311

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Cash Bank In Hand

2012£9,523

2013£0

2014£404

2015£49

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Creditors Due After One Year

2012—

2013£0

2014£63,211

2015£63,625

2016£56,768

2017£56,635

2018—

2019—

2020—

2021—

2022—

2023—

Creditors Due Within One Year

2012£1,474

2013£65,917

2014£63,211

2015—

2016£0

2017£0

2018—

2019—

2020—

2021—

2022—

2023—

Net Assets Liabilities Including Pension Asset Liability

2012£10,630

2013£-65,753

2014£-62,550

2015£-62,904

2016£-51,588

2017£-51,805

2018—

2019—

2020—

2021—

2022—

2023—

Profit Loss Account Reserve

2012£-29,584

2013£-107,864

2014£-111,186

2015£-111,875

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Share Capital Allotted Called Up Paid

2012£11,315

2013£12,353

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Shareholder Funds

2012£10,630

2013£-65,753

2014£-62,550

2015£-62,904

2016£-51,588

2017£-51,805

2018—

2019—

2020—

2021—

2022—

2023—

Share Premium Account

2012£28,899

2013£29,758

2014£29,758

2015£29,758

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Total Liabilities

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021£39,104

2022£20,709

2023£199

公制	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
利润/（亏损）	£-29,584	£-107,864	£-111,186	£-111,875	—	—	—	—	—	—	—	—
总资产	£10,630	£-65,753	£-62,550	£-62,904	£-51,588	£51,806	£52,227	£52,227	£52,279	£23,853	£108	£199
Net Assets Liabilities	—	—	—	—	—	£51,806	£52,227	£52,227	£52,279	—	—	—
Equity	—	—	—	—	—	£51,806	£52,227	£52,227	£52,279	£23,853	£108	—
Current Assets	£12,104	£164	£661	£721	£5,180	£4,829	£4,771	£4,771	£4,719	£39,104	£20,709	£199
Net Current Assets Liabilities	£10,630	£-65,753	£661	£721	£5,180	£51,806	£52,227	£4,771	£4,719	—	—	—
Total Assets Less Current Liabilities	£10,630	£-65,753	£661	£721	£5,180	£51,806	£52,227	£4,771	£4,719	—	—	—
Debtors	£2,581	£164	£257	£252	—	—	—	—	—	—	—	—
Creditors	—	—	—	—	—	£56,635	£56,998	£56,998	£56,998	£15,250	£20,601	£199
Number Shares Allotted	226,300	247,064	—	—	—	—	—	—	—	—	—	—
Par Value Share	—	£0	—	—	—	—	—	—	—	—	—	—
Average Number Employees During Period	—	—	—	—	—	—	—	—	1	0	0	0
Accrued Liabilities Not Expressed Within Creditors Subtotal	—	—	—	—	—	—	—	—	—	£1	—	—
Called Up Share Capital	£11,315	£12,353	£18,878	£22,311	—	—	—	—	—	—	—	—
Cash Bank In Hand	£9,523	£0	£404	£49	—	—	—	—	—	—	—	—
Creditors Due After One Year	—	£0	£63,211	£63,625	£56,768	£56,635	—	—	—	—	—	—
Creditors Due Within One Year	£1,474	£65,917	£63,211	—	£0	£0	—	—	—	—	—	—
Net Assets Liabilities Including Pension Asset Liability	£10,630	£-65,753	£-62,550	£-62,904	£-51,588	£-51,805	—	—	—	—	—	—
Profit Loss Account Reserve	£-29,584	£-107,864	£-111,186	£-111,875	—	—	—	—	—	—	—	—
Share Capital Allotted Called Up Paid	£11,315	£12,353	—	—	—	—	—	—	—	—	—	—
Shareholder Funds	£10,630	£-65,753	£-62,550	£-62,904	£-51,588	£-51,805	—	—	—	—	—	—
Share Premium Account	£28,899	£29,758	£29,758	£29,758	—	—	—	—	—	—	—	—
Total Liabilities	—	—	—	—	—	—	—	—	—	£39,104	£20,709	£199

EXHALATION MEDICAL TECHNOLOGY LTD

摘要

法律与地位

时间轴（28事件）

提交年度账目

提交年度账目

就任 Oliver John Diggle (个人)

网络

所有权和管理权

Persons with significant control

Officers & directors

所有权时间轴（1变化）

就任 Statement Active (个人)

股东名单

最终实益拥有人

地理

财务

主要数据

文件

EXHALATION MEDICAL TECHNOLOGY LTD 公司报告

Accounts for a dormant company made up to 31 July 2025

Confirmation statement

Micro company accounts made up to 31 July 2024

Companexia Document AI

Confirmation statement

Annual Accounts

Micro company accounts made up to 31 July 2023

Confirmation statement

Annual Accounts

Micro company accounts made up to 31 July 2022

浏览更多公司与人物

财务健康度

增长

效率与回报

营运资金与流动性

资本结构